Effect of 6-wk estrogen withdrawal or replacement on myocardial ischemic tolerance in rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 4 47-4, 2000, Pages

  McNulty, Patrick H ^a,b   Jagasia, Dinesh ^a   Whiting, Jennifer M ^a   Caulin Glaser, Teresa ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Coronary artery disease; Gender; Menopause

Indexed keywords

ESTROGEN;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; ESTROGEN METABOLISM; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HORMONAL REGULATION; MENOPAUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR;

EID: 0034051942     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.4.h1030     Document Type: Article

References (36)

1. Abu-Halawa S, Thompson K, Kirkeeide R, Vaughn W, Rosales O, Fujisi K, Schroth G, Smalling R, and Anderson HV. Estrogen replacement therapy and outcome of coronary balloon angioplasty in postmenopausal women. Am J Cardiol 82: 409-413, 1998.
2. Barrett-Conner E and Bush TL. Estrogen and coronary heart disease in women. JAMA 265: 1861-1867, 1991.
3. Bush TL, Barrett-Conner E, Cowan L, Criqui M, Wallace R, Suchindran C, Tyroler H, and Rifkind B. Cardiovascular mortality and noncontraceptive estrogen use in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 75: 1102-1109, 1987.
4. Chang WC, Nakano J, Orimo H, and Murota S. Stimulation of PG cyclooxygenase and prostacyclin synthase activities by estradiol in rat aortic smooth muscle cells. Biochim Biophys Acta 620: 472-478, 1980.
5. Colditz G, Willett M, Stampfer M, Rosner B, Speizer F, and Hennekens C. Menopause and the risk of coronary heart disease in women. N Engl J Med 316: 1105-1110, 1987.
6. Drici M, Burklow T, Haridasse V, Glazer R, and Woosley R. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 94: 1471-1474, 1996.
7. Gardner DG, Gertz BJ, Deschepper CF, and Kim DY. Gene for the rat atrial natriuretic peptide is regulated by glucocorticoids in vitro. J Clin Invest 82: 1275-1281, 1988.
8. Gilligan DM, Quyyumi AA, and Cannon RO. Effects of physiologic levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 89: 2545-2551, 1994.
9. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, and Hennekens CH. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 335: 453-461, 1996.
10. Grohe C, Kahlert S, Lobbert K, Neyses L, Mvan Eickels Stimpel M, and Vetter H. Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth. J Hypertens 16: 377-384, 1998.
11. Grohe C, Kahlert S, Lobbert K, Stimpel M, Karas R, Vetter H, and Neyses L. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 416: 107-112, 1997.
12. Heckbert S, Weiss N, Koepsell T, Lemaitre R, Smith N, Siscovick D, Lin D, and Psaty B. Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women. Arch Intern Med 157: 1330-1336, 1997.
13. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, and Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605-613, 1998.
14. Hutter M, Sievers R, Barbosa V, and Wolfe C. Heat-shock protein induction in rat hearts. A direct correlation between the amount of heat-shock protein induced and the degree of myocardial protection. Circulation 89: 355-360, 1994.
15. Kim YD, Chen B, Beauregard J, Kouretas P, Thomas G, Farhat MY, Myers A, and Lees D. 17β-estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion. Circulation 94: 2901-2908, 1996.
16. Kunapuli S, Benedict C, and Kumar A. Tissue specific hormonal regulation of the rat angiotensinogen gene expression. Arch Biochem Biophys 254: 642-646, 1987.
17. Lafferty F and Fiske ME. Postmenopausal estrogen replacement: a long-term cohort study. Am J Med 97: 66-77, 1994.
18. Li Y, Whittaker P, and Kloner R. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmias. Am Heart J 123: 346-353, 1992.
19. Maxwell MP, Hearse DJ, and Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 21: 737-746, 1987.
20. McHugh N, Cook S, Schairer J, Bidgoli M, and Merrill G. Ischemia-and reperfusion-induced ventricular arrhythmias in dogs: effects of estrogen. Am J Physiol Heart Circ Physiol 268: H2569-H2573, 1995.
21. McNulty PH, Darling A, and Whiting JM. Glycogen depletion contributes to ischemic preconditioning in the rat heart in vivo. Am J Physiol Heart Circ Physiol 271: H2283-H2289, 1996.
22. McNulty PH and Luba MC. Transient ischemia induces regional myocardial glycogen synthase activation and glycogen synthesis in vivo. Am J Physiol Heart Circ Physiol 268: H364-H370, 1995.
23. Mugge A, Riedel M, Barton M, Kuhn M, and Lichtlen P. Endothelium independent relaxation of human coronary arteries by 17beta-oestradiol in vitro. Cardiovasc Res 27: 1939-1942, 1993.
24. Node K, Kitakaze M, Kosaka H, Minamino T, Funaya H, and Hori M. Amelioration of ischemia-and reperfusion-induced myocardial injury by 17β-estradiol: role of nitric oxide and calcium-activated potassium channels. Circulation 96: 1953-1963, 1997.
25. O'Keefe JH, Kim SC, Hall RR, Cochran VC, Lawhorn SL, and McCallister BD. Estrogen replacement therapy after coronary angioplasty in women. JAm Coll Cardiol 29: 1-5, 1997.
26. Pelzer T, Shamim A, Wolfges S, Schumann M, and Neyses L. Modulation of cardiac hypertrophy by estrogens. Adv Exp Med Biol 432: 83-89, 1997.
27. Phillips G, Pinkernell B, and Jing T. The association of hyperestrogenemia with coronary thrombosis in men. Arterioscler Thromb Vasc Biol 16: 1383-1387, 1996.
28. Rubanyi G, Johns A, and Dole W. Increased collateral blood flow to ischemic myocardium by estrogen replacement therapy may contribute to reduced incidence of fatal and nonfatal acute myocardial infarction in postmenopausal women. Endothelium 5: 139-141, 1997.
29. Scheuer J, Malhotra A, Schaible T, and Capasso J. Effects of gonadectomy and hormonal replacement on rat hearts. Circ Res 61: 12-19, 1987.
30. Shiki K, and Hearse DJ. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol Heart Circ Physiol 253: H1470-H1476, 1987.
31. Speechly-Dick ME, Mocanu MM, and Yellon DM. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res 75: 586-590, 1994.
32. Squadrito F, Altavilla D, Squadrito G, Campo G, Arlottta M, Arcoraci V, Minutoli L, Serrano M, Saitta A, and Caputi A. 17β-oestradiol reduces cardiac leukocyte accumulation in myocardial ischemia reperfusion injury in rat. Eur J Pharmacol 335: 185-192, 1997.
33. Weiner CP, Lizasoain I, Bayleis SA, Knowless RG, Charles IG, and Moncada S. Induction of calcium dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 91: 5212-5216, 1994.
34. Williams J, Adams M, and Klopfenstein H. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81: 1680-1687, 1990.
35. Wolf P, Mandans J, Finucane F, Higgins M, and Kleinman J. Reduction in cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort. Am J Obstet Gynecol 164: 489-494, 1991.
36. Yamashita N, Hoshida S, Taniguchi N, Kuzuya T, and Hori M. A second window of protection occurs 24 h after ischemic preconditioning in the rat heart. J Mol Cell Cardiol 30: 1181-1189, 1998.